Comparing laser and cryotherapy for retinal detachment treatment
Official title: Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy: a Randomized Clinical Trial
Run by Clinical Hospital Center, Split · NCT06694259 · Data updated 2026-11-12
This study is testing whether laser treatment or freezing treatment works better for fixing retinal detachment in patients with certain types of retinal tears.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Clinical Hospital Center, Split Academic / other |
| Locations | 1 site (Split) |
| Status | Recruiting |
| Started | December 18, 2024 |
| Main results expected | November 2025 |
| Study ends | December 2025 |
| Registry record updated | December 19, 2024 |
| Trial ID | NCT06694259 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with rhegmatogenous retinal detachment involving one or more tears in the upper half of the retina.
✕Probably not a fit
Patients with lower retinal tears, multiple tears, or other complicating factors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of two surgical techniques, laser photocoagulation and transscleral cryopexy, in treating rhegmatogenous retinal detachment using pneumatic retinopexy. Forty patients with specific retinal tears will be randomly assigned to receive one of the two interventions during the same surgical procedure. The study aims to assess both anatomical and functional outcomes following treatment, with careful monitoring of intraocular pressure and retinal perfusion. Patients will be informed about the risks and benefits of the procedures before participation.
Why it matters
Potential benefit: If successful, this study could improve surgical outcomes and vision preservation for patients with retinal detachment.
How similar studies have gone: Previous studies have shown varying success with similar surgical techniques, but this specific comparison is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with rhegmatogenous retinal detachment with one or more tears within two clock hours, limited to the upper half of the retina Exclusion Criteria: * Patients with tears in the lower half of the retina * Patients with multiple retinal tears covering more than two clock hours * Patients with developed proliferative vitreoretinopathy * Patients with vitreous hemorrhage * Patients with opaque optical media due to other conditions that could obstruct a detailed fundus examination or the procedure itself * Patients unable to follow postoperative head positioning instructions * Patients under age of 18 years
Where it's running
-
Clinical Hospital Center, Split
Split, Croatia Recruiting
Study contacts
- Principal investigator: Ivan Borjan, MD — Clinical Hospital Center, Split
- Study coordinator: Ivan Borjan, MD
- Email: ivan.borjan@kbsplit.hr
- Phone: +385981715350
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of Silicone Oil on Retinal Electrical Function Measured by Multifocal ERG
This study tests how silicone oil as a temporary eye tamponade affects retinal function in people with a primary rhegmatogenous retinal detachment.
-
Human amniotic membrane patches to seal inferior retinal breaks
This trial will try using human amniotic membrane (hAM) patches during vitrectomy to seal inferior retinal breaks in adults with rhegmatogenous retinal detachment.
-
Comparing vitrectomy alone to vitrectomy with cataract removal for retinal detachment
This study is testing whether doing just vitrectomy or adding cataract removal helps older adults with retinal detachment see better and have fewer problems after surgery.
-
Preventing vision loss after retinal detachment surgery with methotrexate
This study is testing if a medication called methotrexate can help prevent vision loss from complications after retinal detachment surgery in adults.
-
Topical netarsudil to prevent scar-like membranes after retinal detachment surgery
This trial will test whether once-daily netarsudil eye drops given before and after vitrectomy can help prevent proliferative vitreoretinopathy (scar tissue) in adults with retinal detachment or established PVR.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.